Saturday, 27 March 2010

Menograine




Menograine may be available in the countries listed below.


Ingredient matches for Menograine



Clonidine

Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Menograine in the following countries:


  • South Africa

International Drug Name Search

Thursday, 25 March 2010

Sultamicilina




Sultamicilina may be available in the countries listed below.


Ingredient matches for Sultamicilina



Sultamicillin

Sultamicillin is reported as an ingredient of Sultamicilina in the following countries:


  • Colombia

  • Venezuela

International Drug Name Search

Sunday, 21 March 2010

Enterogast




Enterogast may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Enterogast



Neomycin

Neomycin sulfate (a derivative of Neomycin) is reported as an ingredient of Enterogast in the following countries:


  • Poland

Sulfaguanidine

Sulfaguanidine is reported as an ingredient of Enterogast in the following countries:


  • Poland

International Drug Name Search

Thursday, 18 March 2010

Increlex


Increlex is a brand name of mecasermin, approved by the FDA in the following formulation(s):


INCRELEX (mecasermin recombinant - injectable; subcutaneous)



  • Manufacturer: TERCICA

    Approval date: August 30, 2005

    Strength(s): 40MG/4ML (10MG/ML) [RLD]

Has a generic version of Increlex been approved?


No. There is currently no therapeutically equivalent version of Increlex available.


Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Increlex. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Formulated IGF-I Composition
    Patent 5,681,814
    Issued: October 28, 1997
    Inventor(s): Clark; Ross G. & Yeung; Douglas A. & Oeswein; James Q.
    Assignee(s): Genentech, Inc.
    A formulation for IGF-I is disclosed that is useful in treating hyperglycemic disorders and, in combination with growth hormone, in enhancing growth of a mammal. Also disclosed is a process for preparing a formulation of growth hormone and IGF-I from the IGF-I formulation. The IGF-I formulation comprises about 2-20 mg/ml of IGF-I, about 2-50 mg/ml of an osmolyte, about 1-15 mg/ml of a stabilizer, and a buffered solution at about pH 5-5.5, optionally with a surfactant.
    Patent expiration dates:

    • September 18, 2017
      ✓ 
      Drug product




  • Treatment of partial growth hormone insensitivity syndrome
    Patent 5,824,642
    Issued: October 20, 1998
    Inventor(s): Attie; Kenneth & Carlsson; Lena M. S. & Gesundheit; Neil & Goddard; Audrey
    Assignee(s): Genentech, Inc.
    Methods for increasing the growth rate of a human patient having partial growth hormone insensitivity syndrome, but not Laron syndrome, are described. One such method comprises administering an effective dose of growth hormone, preferably growth hormone with a native human sequence, with or without an N-terminal methionine, to the patient. The patient is characterized as having a height of less than about -2 standard deviations below normal for age and sex, a serum level of high-affinity growth hormone binding protein that is at least 2 standard deviations below normal levels, a serum level of IGF-I that is below normal mean levels, and a serum level of growth hormone that is at least normal. In another such method, the same patient population is treated with an effective amount of IGF-I, given alone or in combination with an amount of growth hormone that is effective in combination with the IGF-I.
    Patent expiration dates:

    • July 8, 2014
      ✓ 
      Patent use: TREATMENT OF PRIMARY IGF-1 DEFICIENCY




  • Treatment of partial growth hormone insensitivity syndrome
    Patent 6,207,640
    Issued: March 27, 2001
    Inventor(s): Attie; Kenneth M. & Carlsson; Lena M. S. & Gesundheit; Neil & Goddard; Audrey
    Assignee(s): Genentech, Inc.
    Methods for increasing the growth rate of a human patient having partial growth hormone insensitivity syndrome, but not Laron syndrome, are described. One such method comprises administering an effective dose of growth hormone, preferably growth hormone with a native human sequence, with or without an N-terminal methionine, to the patient. The patient is characterized as having a height of less than about -2 standard deviations below normal for age and sex, a serum level of high-affinity growth hormone binding protein that is at least 2 standard deviations below normal levels, a serum level of IGF-I that is below normal mean levels, and a serum level of growth hormone that is at least normal. In another such method, the same patient population is treated with an effective amount of IGF-I, given alone or in combination with an amount of growth hormone that is effective in combination with the IGF-I.
    Patent expiration dates:

    • April 7, 2014
      ✓ 
      Patent use: TREATMENT OF PRIMARY IGF-1 DEFICIENCY



Related Exclusivities

Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.

  • Exclusivity expiration dates:
    • August 30, 2010 - NEW CHEMICAL ENTITY

    • August 30, 2012 - ORPHAN DRUG EXCLUSIVITY

See also...

  • Increlex Consumer Information (Drugs.com)
  • Increlex Consumer Information (Wolters Kluwer)
  • Increlex Consumer Information (Cerner Multum)
  • Increlex Advanced Consumer Information (Micromedex)
  • Increlex AHFS DI Monographs (ASHP)
  • Mecasermin Consumer Information (Wolters Kluwer)
  • Mecasermin Consumer Information (Cerner Multum)
  • Iplex Advanced Consumer Information (Micromedex)
  • Mecasermin Subcutaneous Advanced Consumer Information (Micromedex)
  • Mecasermin AHFS DI Monographs (ASHP)

Snizex




Snizex may be available in the countries listed below.


Ingredient matches for Snizex



Azelastine

Azelastine hydrochloride (a derivative of Azelastine) is reported as an ingredient of Snizex in the following countries:


  • Bangladesh

International Drug Name Search

Monday, 15 March 2010

Sotalol HCl Katwijk




Sotalol HCl Katwijk may be available in the countries listed below.


Ingredient matches for Sotalol HCl Katwijk



Sotalol

Sotalol hydrochloride (a derivative of Sotalol) is reported as an ingredient of Sotalol HCl Katwijk in the following countries:


  • Netherlands

International Drug Name Search

Sunday, 14 March 2010

Faverin




Faverin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

UK matches:

  • Faverin Tablets 50 or 100 mg film-coated tablets
  • Faverin 50mg film-coated tablets (SPC)

Ingredient matches for Faverin



Fluvoxamine

Fluvoxamine maleate (a derivative of Fluvoxamine) is reported as an ingredient of Faverin in the following countries:


  • Australia

  • Bahrain

  • Hong Kong

  • Ireland

  • Malta

  • Oman

  • Philippines

  • Singapore

  • South Africa

  • Turkey

  • United Kingdom

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Saturday, 13 March 2010

Amoxicilline / Acide Clavulanique Arrow




Amoxicilline/Acide Clavulanique Arrow may be available in the countries listed below.


Ingredient matches for Amoxicilline/Acide Clavulanique Arrow



Amoxicillin

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxicilline/Acide Clavulanique Arrow in the following countries:


  • France

Clavulanate

Clavulanic Acid potassium (a derivative of Clavulanic Acid) is reported as an ingredient of Amoxicilline/Acide Clavulanique Arrow in the following countries:


  • France

International Drug Name Search

Saturday, 6 March 2010

Allerfre




Allerfre may be available in the countries listed below.


Ingredient matches for Allerfre



Loratadine

Loratadine is reported as an ingredient of Allerfre in the following countries:


  • Netherlands

International Drug Name Search

Friday, 5 March 2010

Urigon




Urigon may be available in the countries listed below.


Ingredient matches for Urigon



Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Urigon in the following countries:


  • Estonia

  • Greece

  • Malta

International Drug Name Search

rifampin and isoniazid


rif-AM-pin, eye-soe-NYE-a-zid


Oral route(Capsule)

Severe and sometimes fatal hepatitis has been reported with isoniazid therapy and may occur even after many months of treatment. The risk for hepatitis increases with advancing age and alcohol use. Monthly clinical evaluation and liver function tests should be performed .



Commonly used brand name(s)

In the U.S.


  • IsonaRif

  • Rifamate

Available Dosage Forms:


  • Capsule

  • Tablet

Therapeutic Class: Antitubercular Combination


Chemical Class: Rifamycin


Uses For rifampin and isoniazid


Rifampin and isoniazid is a combination antibiotic and anti-infective medicine. This combination medication is used to treat tuberculosis (TB). It may be taken alone or with one or more other medicines for TB.


To help clear up your tuberculosis (TB) infection completely, you must keep taking rifampin and isoniazid for the full time of treatment, even if you begin to feel better. This is very important. It is also important that you do not miss any doses.


Rifampin and isoniazid combination is available only with your doctor's prescription.


Before Using rifampin and isoniazid


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For rifampin and isoniazid, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to rifampin and isoniazid or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Rifampin and isoniazid combination is not recommended for use in children.


Geriatric


Liver problems are more likely to occur in patients over 50 years of age who are taking isoniazid-containing medicines.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersCAnimal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking rifampin and isoniazid, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using rifampin and isoniazid with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Atazanavir

  • Boceprevir

  • Darunavir

  • Fosamprenavir

  • Lopinavir

  • Lurasidone

  • Nifedipine

  • Praziquantel

  • Ranolazine

  • Rilpivirine

  • Saquinavir

  • Telaprevir

  • Tipranavir

  • Voriconazole

Using rifampin and isoniazid with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Abiraterone

  • Amiodarone

  • Amprenavir

  • Atovaquone

  • Cabazitaxel

  • Crizotinib

  • Cyclosporine

  • Dabigatran Etexilate

  • Dasatinib

  • Delavirdine

  • Dronedarone

  • Efavirenz

  • Erlotinib

  • Ethionamide

  • Etravirine

  • Everolimus

  • Imatinib

  • Indinavir

  • Irinotecan

  • Isoniazid

  • Itraconazole

  • Ixabepilone

  • Lapatinib

  • Levodopa

  • Linagliptin

  • Lorcainide

  • Maraviroc

  • Mycophenolate Mofetil

  • Nelfinavir

  • Nevirapine

  • Nilotinib

  • Pazopanib

  • Posaconazole

  • Pyrazinamide

  • Quetiapine

  • Quinine

  • Rifampin

  • Ritonavir

  • Rivaroxaban

  • Roflumilast

  • Romidepsin

  • Sirolimus

  • Sunitinib

  • Tacrolimus

  • Telithromycin

  • Temsirolimus

  • Ticagrelor

  • Tolvaptan

  • Vandetanib

  • Vemurafenib

Using rifampin and isoniazid with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Acetaminophen

  • Acetyldigoxin

  • Aliskiren

  • Aminosalicylic Acid

  • Anisindione

  • Aprepitant

  • Atorvastatin

  • Betamethasone

  • Bexarotene

  • Bosentan

  • Buspirone

  • Carbamazepine

  • Carvedilol

  • Caspofungin

  • Chloramphenicol

  • Chlorpropamide

  • Citalopram

  • Clarithromycin

  • Clofibrate

  • Clozapine

  • Cortisone

  • Deferasirox

  • Desogestrel

  • Dexamethasone

  • Diazepam

  • Dicumarol

  • Dienogest

  • Digoxin

  • Diltiazem

  • Disopyramide

  • Disulfiram

  • Doxycycline

  • Drospirenone

  • Eltrombopag

  • Enalaprilat

  • Enalapril Maleate

  • Enflurane

  • Estradiol Cypionate

  • Estradiol Valerate

  • Ethinyl Estradiol

  • Ethionamide

  • Ethynodiol Diacetate

  • Etonogestrel

  • Fentanyl

  • Fesoterodine

  • Fluconazole

  • Fludrocortisone

  • Fosaprepitant

  • Fosphenytoin

  • Gefitinib

  • Gliclazide

  • Glyburide

  • Haloperidol

  • Isradipine

  • Ketoconazole

  • Lamotrigine

  • Leflunomide

  • Levomethadyl

  • Levonorgestrel

  • Levothyroxine

  • Linezolid

  • Losartan

  • Medroxyprogesterone Acetate

  • Mefloquine

  • Meperidine

  • Mestranol

  • Metformin

  • Methadone

  • Methylprednisolone

  • Metoprolol

  • Morphine

  • Morphine Sulfate Liposome

  • Moxifloxacin

  • Nisoldipine

  • Norelgestromin

  • Norethindrone

  • Norgestimate

  • Norgestrel

  • Oxycodone

  • Phenprocoumon

  • Phenytoin

  • Pioglitazone

  • Pirmenol

  • Pitavastatin

  • Prednisolone

  • Prednisone

  • Propafenone

  • Raltegravir

  • Repaglinide

  • Rofecoxib

  • Rosiglitazone

  • Ruxolitinib

  • Sertraline

  • Simvastatin

  • Tadalafil

  • Tamoxifen

  • Theophylline

  • Tocainide

  • Triazolam

  • Trimetrexate

  • Valproic Acid

  • Warfarin

  • Zaleplon

  • Zidovudine

  • Zolpidem

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using rifampin and isoniazid with any of the following is usually not recommended, but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use rifampin and isoniazid, or give you special instructions about the use of food, alcohol, or tobacco.


  • Ethanol

Using rifampin and isoniazid with any of the following may cause an increased risk of certain side effects but may be unavoidable in some cases. If used together, your doctor may change the dose or how often you use rifampin and isoniazid, or give you special instructions about the use of food, alcohol, or tobacco.


  • food

  • Tyramine Containing Food

Other Medical Problems


The presence of other medical problems may affect the use of rifampin and isoniazid. Make sure you tell your doctor if you have any other medical problems, especially:


  • Alcohol abuse (or history of) or

  • Liver disease—There may be an increased chance of getting hepatitis if you take rifampin and isoniazid and drink alcohol daily

  • Convulsive disorders such as seizures or epilepsy—Rifampin and isoniazid combination may increase the frequency of seizures (convulsions) in some patients

  • Kidney disease (severe)—There may be an increased chance of side effects in patients with severe kidney disease

Proper Use of rifampin and isoniazid


If rifampin and isoniazid upsets your stomach, take it with food. Antacids may also help. However, do not take aluminum-containing antacids within 1 hour of the time you take rifampin and isoniazid combination. They may keep rifampin and isoniazid from working properly.


To help clear up your tuberculosis (TB) completely, it is very important that you keep taking rifampin and isoniazid for the full time of treatment, even if you begin to feel better after a few weeks. You may have to take it every day for as long as 1 to 2 years or more. It is important that you do not miss any doses.


Your doctor may also want you to take pyridoxine (e.g., Hexa-Betalin, vitamin B 6) every day to help prevent or lessen some of the side effects of isoniazid. If it is needed, it is very important to take pyridoxine every day along with rifampin and isoniazid. Do not miss any doses.


Dosing


The dose of rifampin and isoniazid will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of rifampin and isoniazid. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For the oral dosage form (capsules):
    • For the treatment of tuberculosis:
      • Adults and older children—600 milligrams (mg) of rifampin and 300 mg of isoniazid once a day.

      • Children—This combination medicine is not recommended for use in children.



Missed Dose


If you miss a dose of rifampin and isoniazid, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using rifampin and isoniazid


It is very important that your doctor check your progress at regular visits. In addition, you should check with your doctor immediately if blurred vision or loss of vision, with or without eye pain, occurs during treatment. He or she may want you to have your eyes checked by an ophthalmologist (eye doctor).


If your symptoms do not improve within 2 to 3 weeks, or if they become worse, check with your doctor.


Oral contraceptives (birth control pills) containing estrogen may not work properly if you take them while you are taking rifampin and isoniazid combination. Unplanned pregnancies may occur. You should use a different means of birth control while you are taking rifampin and isoniazid. If you have any questions about this, check with your health care professional.


Liver problems may be more likely to occur if you drink alcoholic beverages regularly while you are taking rifampin and isoniazid. Also, the regular use of alcohol may keep rifampin and isoniazid from working properly. Therefore, you should strictly limit the amount of alcoholic beverages you drink while you are taking rifampin and isoniazid.


Certain foods such as cheese (Swiss or Cheshire) or fish (tuna, skipjack, or Sardinella) may rarely cause reactions in some patients taking isoniazid-containing medicines. Check with your doctor if redness or itching of the skin, hot feeling, fast or pounding heartbeat, sweating, chills or clammy feeling, headache, or lightheadedness occurs after eating these foods while you are taking rifampin and isoniazid.


rifampin and isoniazid will cause the urine, stool, saliva, sputum, sweat, and tears to turn reddish-orange to reddish-brown. This is to be expected while you are taking rifampin and isoniazid. This effect may cause soft contact lenses to become permanently discolored. Standard cleaning solutions may not take out all the discoloration. Therefore, it is best not to wear soft contact lenses while taking rifampin and isoniazid. This condition will return to normal once you stop taking rifampin and isoniazid. Hard contact lenses are not discolored by rifampin and isoniazid. If you have any questions about this, check with your doctor.


If rifampin and isoniazid causes you to feel very tired or very weak; or causes clumsiness; unsteadiness; a loss of appetite; nausea; numbness, tingling, burning, or pain in the hands and feet; or vomiting, stop taking it and check with your doctor immediately. These may be early warning symptoms of more serious liver or nerve problems that could develop later.


Rifampin and isoniazid combination may cause blood problems. These problems may result in a greater chance of certain infections, slow healing, and bleeding of the gums. Therefore, you should be careful when using regular toothbrushes, dental floss, and toothpicks. Dental work should be delayed until your blood counts have returned to normal. Check with your medical doctor or dentist if you have any questions about proper oral hygiene (mouth care) during treatment.


rifampin and isoniazid Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Clumsiness or unsteadiness

  • dark urine

  • loss of appetite

  • nausea and vomiting

  • numbness, tingling, burning, or pain in hands and feet

  • unusual tiredness or weakness

  • yellow eyes or skin

Less common
  • Chills

  • difficult breathing

  • dizziness

  • fever

  • headache

  • itching

  • muscle and bone pain

  • shivering

  • skin rash and redness

Rare
  • Bloody or cloudy urine

  • blurred vision or loss of vision, with or without eye pain

  • convulsions (seizures)

  • depression

  • greatly decreased frequency of urination or amount of urine

  • mood or mental changes

  • sore throat

  • unusual bleeding or bruising

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Diarrhea

  • stomach pain or upset

Less common
  • Sore mouth or tongue

rifampin and isoniazid commonly causes reddish-orange to reddish-brown discoloration of urine, stool, saliva, sputum, sweat, and tears. This side effect does not usually require medical attention.


Dark urine and yellowing of the eyes or skin (signs of liver problems) are more likely to occur in patients 50 years of age and older.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: rifampin and isoniazid side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More rifampin and isoniazid resources


  • Rifampin and isoniazid Side Effects (in more detail)
  • Rifampin and isoniazid Use in Pregnancy & Breastfeeding
  • Rifampin and isoniazid Drug Interactions
  • Rifampin and isoniazid Support Group
  • 0 Reviews for Rifampin and isoniazid - Add your own review/rating


Compare rifampin and isoniazid with other medications


  • Tuberculosis, Active

Thursday, 4 March 2010

Relistor


Generic Name: methylnaltrexone (Subcutaneous route)

meth-il-nal-TREX-one

Commonly used brand name(s)

In the U.S.


  • Relistor

Available Dosage Forms:


  • Solution

Therapeutic Class: Gastrointestinal Agent


Pharmacologic Class: Opioid Antagonist


Uses For Relistor


Methylnaltrexone injection is used to treat constipation caused by pain medicines called opioids (narcotics) in patients with severe illness. This medicine is used when other medicines for constipation (laxatives) have not worked well.


This medicine is available only with your doctor's prescription.


Before Using Relistor


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of methylnaltrexone injection in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of methylnaltrexone injection in the elderly.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Bowel blockage—Should not be used in patients with this condition.

  • Kidney disease, severe—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

  • Ogilvie's syndrome (decreased movement of food in the intestines) or

  • Stomach or intestinal ulcers or problems (e.g., cancer, perforation)—Use with caution. May make these conditions worse.

Proper Use of Relistor


Your doctor will prescribe your exact dose and tell you how often it should be given. This medicine is given as a shot under your skin (usually in the upper arm, abdomen, or thighs). Methylnaltrexone may be given at home to patients who do not need to be in the hospital. If you are using this medicine at home, your doctor will teach you how to prepare and inject the medicine. Be sure that you understand exactly how the medicine is prepared and injected.


This medicine comes with patient instructions. Read and follow these instructions carefully. Ask your doctor if you have any questions.


You will be shown the body areas where this shot can be given. Use a different body area each time you give yourself a shot. Keep track of where you give each shot to make sure you change body areas. This will help prevent skin problems from the injections. Do not inject into skin areas that are bruised, red, tender, or hard.


Use a new needle and syringe each time you inject your medicine.


You might not use all of the medicine in each vial (glass container). Use each vial or syringe only one time. Do not save an open vial or syringe. If the medicine in the vial or syringe has changed color, or if you see particles in it, do not use it.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For injection dosage form:
    • For constipation caused by opioids:
      • Adults weighing more than 114 kilograms (more than 251 pounds)—Dose is based on body weight and must be determined by your doctor. The dose is 0.15 milligram (mg) per kilogram (kg) of body weight injected under the skin every other day.

      • Adults weighing 62 to 114 kg (136 to 251 pounds)—Dose is based on body weight and must be determined by your doctor. The dose is usually 12 mg injected under the skin every other day.

      • Adults weighing 38 to less than 62 kg (84 to less than 136 pounds)—Dose is based on body weight and must be determined by your doctor. The dose is usually 8 mg injected under the skin every other day.

      • Adults weighing less than 38 kg (less than 84 pounds)—Dose is based on body weight and must be determined by your doctor. The dose is 0.15 milligram (mg) per kilogram (kg) of body weight injected under the skin every other day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store unopened vials of this medicine at room temperature, away from heat and direct light. Do not freeze. An open vial of medicine must be used right away.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Throw away used needles in a hard, closed container that the needles cannot poke through. Keep this container away from children and pets.


Precautions While Using Relistor


It is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it.


If severe or persistent (non-stop) diarrhea occurs while using methylnaltrexone injection, stop using this medicine and check with your doctor right away.


Stop using this medicine and check with your doctor right away if you have severe abdominal or stomach pain or cramps; bloody, black, or tarry stools; heartburn; indigestion; nausea; or vomiting of material that looks like coffee grounds. These could be symptoms of a serious bowel problem called intestinal perforation.


Relistor Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Diarrhea

  • increased sweating

Incidence not known
  • Bloody, black, or tarry stools

  • heartburn

  • indigestion

  • nausea

  • severe abdominal or stomach pain, cramping, or burning

  • trouble breathing

  • vomiting of material that looks like coffee grounds, severe and continuing

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Chills

  • cold sweats

  • confusion

  • dizziness, faintness, or lightheadedness when getting up from lying or sitting position

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Bloated

  • dizziness

  • excess air or gas in the stomach or intestines

  • full feeling

  • passing gas

  • stomach pain

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Relistor side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Relistor resources


  • Relistor Side Effects (in more detail)
  • Relistor Use in Pregnancy & Breastfeeding
  • Relistor Support Group
  • 7 Reviews for Relistor - Add your own review/rating


  • Relistor Prescribing Information (FDA)

  • Relistor Monograph (AHFS DI)

  • Relistor MedFacts Consumer Leaflet (Wolters Kluwer)

  • Relistor Consumer Overview



Compare Relistor with other medications


  • Constipation, Chronic
  • Constipation, Drug Induced

Monday, 1 March 2010

Summer C-Dip




Summer C-Dip may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Summer C-Dip



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Summer C-Dip in the following countries:


  • United Kingdom

International Drug Name Search